Meeting
2016 ASCO Annual Meeting
Molecular markers and survival after recurrence in stage III colon cancers from NCCTG N0147 and NSABP C-08 adjuvant chemotherapy trials.
Authors
Frank A. Sinicrope
Mayo Clinic, Rochester, MN
Frank A. Sinicrope , Qian Shi , Carmen Joseph Allegra , Thomas C. Smyrk , Stephen N. Thibodeau , Richard M. Goldberg , Jeffrey P. Meyers , Greg Yothers , Daniel J. Sargent , Steven R. Alberts
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Clinical Trial Registration Number
NCCTG N0147; NCT00079274; NSABP C-08; NCT00096278
Citation
J Clin Oncol 34, 2016 (suppl; abstr 3600)
DOI
10.1200/JCO.2016.34.15_suppl.3600
Abstract #
3600
Poster Bd #
297
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Relative contribution of clinical and molecular features to outcome within low and high risk T and N groups in stage III colon cancer (CC).
First Author: Frank A. Sinicrope
Poster
2019 ASCO Annual Meeting
Is the predictive and prognostic impact of sporadic and familial microsatellite instable stage III colon cancer different? A pooled analysis of the PETACC8 and NCCTG N0147 (Alliance) trials.
First Author: Aziz Zaanan
Poster
2015 ASCO Annual Meeting
Influence of molecular alterations on site-specific (ss) time to recurrence (TTR) following adjuvant therapy in resected colon cancer (CC) (Alliance Trial N0147).
First Author: Ryan Eldredge Wilcox
Poster
2016 ASCO Annual Meeting
Association of tumor infiltrating lymphocytes (TILs) with molecular subtype and prognosis in stage III colon cancers (CC) from a FOLFOX-based adjuvant chemotherapy trial.
First Author: Frank A. Sinicrope